Larvol Delta - CostEffectiveness-and-Impact-of-NirmatrelvirRitonavir-in-Reducing-Hospitalizations-Among-Elderly-COVID19-Patients-in-Sweden

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2025/program/program/paper/ispor-europe-2025/poster-session-2-2/cost-effectiveness-and-impact-of-nirmatrelvir-ritonavir-in-reducing-hospitalizations-among-elderly-covid-19-patients-in-sweden

Fredrik Nilsson, MSc, PhD 1; Martina Aldvén, MSc 1; Christian Gerdeskold Rappe, MD, PhD 2.

Nov 11, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next